212 related articles for article (PubMed ID: 1160141)
21. [Safety evaluation of KW-1062. I. Acute toxicity in mice, rats and dogs, subacute and chronic toxicity in rats (author's transl)].
Hara T; Koyama K; Miyazaki H; Ohguro Y; Shimizu M
Jpn J Antibiot; 1977 Jun; 30(6):386-407. PubMed ID: 894836
[No Abstract] [Full Text] [Related]
22. [On the toxicity of CT-1341 evoked by long-term administration. I. Subacute toxicity of the intravenous anesthetic, CT-1341 in rats (author's transl)].
Tanabe T; Shimpo K; Togashi H; Shibata M; Kawakita I
Hokkaido Igaku Zasshi; 1975 Jan; 50(1):43-54. PubMed ID: 1171057
[TBL] [Abstract][Full Text] [Related]
23. [On the acute toxicity of CT-1341, a new steroidal anesthetic agent. (author's transl)].
Tanabe T; Togashi H; Otani T; Shudo I; Tawara K
Hokkaido Igaku Zasshi; 1974 Mar; 49(2):142-52. PubMed ID: 4476697
[No Abstract] [Full Text] [Related]
24. [Blood level of amikacin after drip intravenous infusion (author's transl)].
Sawae Y; Takii M
Jpn J Antibiot; 1980 Apr; 33(4):539-48. PubMed ID: 7411857
[No Abstract] [Full Text] [Related]
25. [Studies on the toxicity of cefadroxil (S-578). II. Subacute toxicity in rats (author's transl)].
Tauchi K; Kawanishi H; Igarashi N; Maeda Y; Maeyama Y; Ebino K; Suzuki K; Imamichi T
Jpn J Antibiot; 1979 Dec; 32(12):1233-57. PubMed ID: 43405
[No Abstract] [Full Text] [Related]
26. [Studies on toxicity of clobetasone-17-butyrate (I)--acute toxicity in mice and rats and subacute toxicity in rats (author's transl)].
Tamura J; Sato N; Moriwaki T; Tatami A; Ezaki H; Nagasawawa R; Aoishi M; Okamura C; Sutoh M; Bando T; Hashimoto K; Matsumoto M
J Toxicol Sci; 1980 Feb; 5(1):45-78. PubMed ID: 7431440
[TBL] [Abstract][Full Text] [Related]
27. [Comparative pharmacokinetics of amikacin after intravenous, intramuscular and subcutaneous administration].
Leng B; Saux MC; Latrille J
Nouv Presse Med; 1979 Oct; 8(42):3421-5. PubMed ID: 537887
[No Abstract] [Full Text] [Related]
28. [Absorption, excretion and distribution of amikacin following intravenous drip infusion. Intravenous drip infusion, one shot intravenous injection and intramuscular administration of amikacin in dogs, rabbits and rats].
Matsumoto H; Ochiai K; Nakajima A; Matsuzaki M
Jpn J Antibiot; 1982 Aug; 35(8):2034-46. PubMed ID: 7154249
[TBL] [Abstract][Full Text] [Related]
29. [On toxicity of massive administration of sodium cephalothin. II. Chronic toxicity (author's transl)].
Kuramoto M; Ishimura Y; Morimoto J; Lee SY; Katori T
Jpn J Antibiot; 1975 Apr; 28(2):195-203. PubMed ID: 1152278
[No Abstract] [Full Text] [Related]
30. [Thirty-day subacute intramuscular toxicity study and thirty-day recovery study of netilmicin in beagle dogs (author's transl)].
Nakazawa M; Tokiwa T; Nomura A; Miyoshi K; Seno N; Honda T
Jpn J Antibiot; 1982 Feb; 35(2):525-613. PubMed ID: 7087180
[No Abstract] [Full Text] [Related]
31. Toxicological studies on dipyridamole in the rat.
Takenaka F; Takeya N; Ishihara T; Higuchi M; Hayashi H
Arzneimittelforschung; 1972 May; 22(5):892-5. PubMed ID: 5068206
[No Abstract] [Full Text] [Related]
32. [Renal toxicity of amikacin and blood level of amikacin in patients with renal dysfunction (author's transl)].
Yamasaku F; Takeda H; Niwayama M; Kawashima S; Iwanaga M
Jpn J Antibiot; 1974 Jun; 27(3):366-9. PubMed ID: 4436950
[No Abstract] [Full Text] [Related]
33. [Chronic toxicity study on netilmicin in rats (author's transl)].
Otaka T; Miyoshi K; Nomura A; Nakayoshi H
Jpn J Antibiot; 1982 Feb; 35(2):499-524. PubMed ID: 7087179
[No Abstract] [Full Text] [Related]
34. [Clinical results with amikacin (BB-K8) in respiratory infections (author's transl)].
Ito T
Jpn J Antibiot; 1976 Aug; 29(8):731-4. PubMed ID: 957522
[No Abstract] [Full Text] [Related]
35. [Evaluation of amikacin (BB-K8) in ophthalmological field (author's transl)].
Hatano H; Tokuda H; Kayaba C
Jpn J Antibiot; 1974 Aug; 27(4):451-5. PubMed ID: 4548096
[No Abstract] [Full Text] [Related]
36. [Toxicological studies on dibekacin for intravenous injection use. II. Chronic toxicity in rats (author's transl)].
Koeda T; Odaki M; Sasaki H; Yokota M; Niizato T; Watanabe H; Kawaoto H; Hirano F; Ishiwatari N; Watanuki T; Senoo A
Jpn J Antibiot; 1980 May; 33(5):599-612. PubMed ID: 7431660
[TBL] [Abstract][Full Text] [Related]
37. [Toxicological studies on fosfomycin-Na salt. I. Acute toxicity in mice and rats (author's transl)].
Koeda T; Odaki M; Sasaki H; Yokota M; Watanabe H; Kawaoto H; Ito T; Ishiwatari N
Jpn J Antibiot; 1979 Jan; 32(1):61-6. PubMed ID: 423368
[TBL] [Abstract][Full Text] [Related]
38. [Experimental studies on topic application of amikacin to the eye (author's transl)].
Krasemann C; Mester U; Stein HJ
Arzneimittelforschung; 1978; 28(9):1602-4. PubMed ID: 582564
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of dermatological cases with BB-K8 (author's transl)].
Kameyama A; Maruta H; Minami K
Jpn J Antibiot; 1975 Aug; 28(4):525-9. PubMed ID: 808656
[TBL] [Abstract][Full Text] [Related]
40. [Clinical studies on amikacin for infectious diseases following intravenous drip infusion (author's transl)].
Nakamura T; Hashimoto I; Sawada Y; Mikami J; Saitoh M; Hattanda K; Bekki E; Nishidai H; Nakanishi M; Kasai Y
Jpn J Antibiot; 1982 Apr; 35(4):897-908. PubMed ID: 7097987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
